poisar

Stock

Elicio Therapeutics, Inc. ELTX

$3.01-4.75%

Overview

ELTX market data

Price History

ELTX price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$4.33
Diluted earnings per share over the trailing twelve months.
Beta
1.32
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$2.66 – $16.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $73.7 · P/B 85.10 · P/S 2.48.

Company news

10 captured
8-K filing — Elicio Therapeutics, Inc. (ELTX)SEC EDGAR · Jul 2, 2026, 10:20 AM
Elicio Therapeutics Added to Russell 2000® and Russell 3000® IndexesGlobenewswire Inc · Jun 29, 2026, 12:15 PM
Elicio Therapeutics Added To Russell 2000, 3000 Indexes, Effective June 26Benzinga · Jun 29, 2026, 12:10 PM
Ladenburg Thalmann Assumes Elicio Therapeutics at Buy, Announces Price Target of $12Benzinga · Jun 18, 2026, 7:10 PM
Elicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer DrugBenzinga · Jun 17, 2026, 4:50 PM
Elicio Therapeutics Reports 100% Complete Responses In Three Metastatic Pancreatic Cancer Patients Following ELI-002 7P And Nivolumab TherapyBenzinga · Jun 17, 2026, 12:25 PM
Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment And Subsequent Therapy With Checkpoint InhibitionBenzinga · Jun 17, 2026, 12:10 PM
Jones Trading Downgrades Elicio Therapeutics to HoldBenzinga · Jun 16, 2026, 4:35 PM
Elicio Therapeutics Pancreatic Cancer Study DisappointsBenzinga · Jun 15, 2026, 4:30 PM
Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In JuneBenzinga · Jun 15, 2026, 4:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock